Understanding how retinal immune cells respond to photoreceptor degeneration
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration
This study is looking at how certain immune cells in the eye help clean up damaged cells in conditions like age-related macular degeneration, with the hope of finding new ways to protect your vision.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10976702 on NIH RePORTER |
What this research studies
This research investigates the role of retinal microglial cells in the context of diseases that cause photoreceptor degeneration, such as age-related macular degeneration (AMD). By analyzing the behavior of these immune cells, the study aims to understand how they help clear out dead photoreceptors and their toxic byproducts, which can otherwise lead to further damage in the retina. The researchers utilize advanced techniques like single-cell RNA sequencing to explore the molecular dynamics of microglia in both animal models and human postmortem tissues. This approach may reveal new therapeutic targets to enhance the protective functions of microglia in retinal diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with age-related macular degeneration or other retinal degenerative diseases.
Not a fit: Patients with retinal conditions unrelated to photoreceptor degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the health of the retina and preserve vision in patients with degenerative eye diseases.
How similar studies have performed: Previous research has shown promising results in understanding the role of microglia in retinal health, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Saban, Daniel Raphael — Duke University
- Study coordinator: Saban, Daniel Raphael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.